Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) Study
评估中风流行病学中基于人群的放射学脑健康 (APRISE) 研究
基本信息
- 批准号:10456166
- 负责人:
- 金额:$ 57.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAncillary StudyAreaAutomobile DrivingBiometryBlack PopulationsBlood VesselsBrain hemorrhageCarotid StenosisCause of DeathCerebrovascular DisordersCerebrumClinicalCollectionDataDiseaseEducational InterventionEpidemiologyEventFamilyFibrinolytic AgentsFundingFutureGeneticGoalsGuidelinesImageIncidenceIndividualInfrastructureInvestigationIschemiaIschemic StrokeKentuckyLacunar InfarctionsMagnetic Resonance ImagingMeasuresMicrovascular DysfunctionMinorModelingModernizationMorbidity - disease rateNational Institute of Neurological Disorders and StrokeOutcomePathway interactionsPatientsPopulationPopulation HeterogeneityPositioning AttributePredispositionPrevalencePublic HealthRadiologic FindingRadiology SpecialtyRecording of previous eventsRecurrenceResearch PriorityRiskRisk FactorsRoleSeveritiesSourceStrokeSurveysTimeTissuesUnited States National Institutes of HealthVascular DementiaWhite Matter HyperintensityWorkbasebiracialbrain healthcareercerebral atrophycerebrovascularclinical careclinical decision-makingclinical investigationcohortdisabilityepidemiology studyhigh riskimaging biomarkerimprovedinnovationmortalitymultidisciplinarynovelparent grantpopulation basedpredictive modelingracial disparityracial diversityspectrographstroke eventstroke patientstroke risktool
项目摘要
DESCRIPTION/ABSTRACT:
Stroke recurrence is a major public health problem. It has been understudied epidemiologically despite
comprising ~25% of all stroke in the US, and leading to higher morbidity and mortality compared to initial
events. Furthermore, compared to our understanding of the role of traditional risk factors for first stroke, we
have limited understanding of the risk factors for recurrent stroke. Radiological measures of small vessel and
large-vessel disease may provide a measure of a subject’s current “Brain Health” to predict future
cerebrovascular events and vascular dementia. Understanding small vessel disease in particular—manifesting
as white matter hyperintensity, microbleeds, lacunar infarcts, dilated perivascular spaces, and brain atrophy–is
a top NINDS priority. Although the Framingham risk score is widely used for clinical decision-making, and the
ABCD scores predict 90-day stroke risk among minor stroke/TIA patients, no clinical prediction tool in a
broader ischemic or a hemorrhagic stroke population-based cohort has been established. A Framingham-like
“Risk Function Tool for Secondary Stroke,” especially one incorporating the full gamut of modern imaging
parameters developed in a racially diverse population, would likely identify high-risk patients for targeted
education interventions, novel antithrombotics, and aggressive clinical care. Moreover, it may reveal novel
causal pathways and risk factors for future investigation. We propose an ancillary study to the ongoing Greater
Cincinnati/Northern Kentucky Stroke Study (GCKNSS) entitled APRISE (Assessing Population-based
Radiological brain health in Stroke Epidemiology). Our objective is to build on the GCNKSS infrastructure
to radiologically characterize the full stroke/TIA population of Greater Cincinnati/Northern Kentucky from 2015
and create the first modern, largely MRI-based characterization of brain health in a contemporary stroke/TIA
population. Our specific aim is to create a prediction model of cerebrovascular disease recurrence
(ischemic or hemorrhagic stroke) incorporating imaging parameters in a biracial, large-scale ischemic
stroke/TIA population using state-of-the-art modeling approaches. We will achieve these goals by
radiologically characterizing the stroke/TIA population (~2700 ischemic and ~525 hemorrhagic stroke, and
~1025 TIA patients) in the NIH-funded GCNKSS of a 1.4 million, biracial population. We will leverage the
extensive GCNKSS infrastructure, which is already in place to detect recurrent stroke, placing us in a unique
position to develop a recurrent stroke risk model using newly acquired radiologic data with remarkable
efficiency. The proposed study will allow the first and only population-based characterization of the entire
imaging spectrum of brain health in stroke/TIA patients. Our multi-disciplinary team with imaging,
epidemiology, outcomes, and biostatistics expertise will address NINDS priority research areas with precision
and innovation currently unavailable.
描述/摘要:
中风复发是一个主要的公共卫生问题。它已被理解为流行病学的需求
与初始相比
事件。此外,与我们对传统风险因素首次中风的作用的理解相比,我们
对复发性中风的危险因素的了解有限。小容器的放射学测量
大周期疾病可以提供对受试者当前的“大脑健康”的量度,以预测未来
脑血管事件和血管痴呆。特别是了解小血管疾病 -
作为白质高强度,微观的,lacunar梗塞,扩张的周围空间和脑萎缩 -
最高的Ninds优先级。尽管Framingham风险评分广泛用于临床决策,但
ABCD分数预测,次要中风/TIA患者的90天中风风险,没有临床预测工具
已经建立了更广泛的缺血性或出血性中风人群的同类群体。像弗雷明汉一样
“次级中风的风险功能工具”,尤其是一种融合了现代成像的全部
在大致多样化的人群中开发的参数可能会识别出针对性的高危患者
教育干预措施,新颖的抗血栓形成和积极的临床护理。而且,它可能揭示小说
未来投资的因果途径和风险因素。我们向正在进行的更大的辅助研究提出了一项辅助研究
辛辛那提/北肯塔基州中风研究(GCKNSS)标题为Aprise(评估基于人群的
中风流行病学中的放射学大脑健康)。我们的目标是建立在GCNKSS基础架构的基础上
在放射学上,从2015年开始的辛辛那提/北部北部的全部中风/TIA人口
并在当代中风/TIA中创建第一个现代的,主要基于MRI的大脑健康表征
人口。我们的具体目的是创建脑血管疾病复发的预测模型
(缺血性或出血性中风)将成像参数纳入混血症,大规模缺血
使用最先进的建模方法中风/TIA种群。我们将通过
放射学表征中风/TIA种群(〜2700缺血性和〜525个出血性中风,以及
〜1025例TIA患者)在140万混血儿人口的NIH资助的GCNKS中。我们将利用
广泛的GCNKSS基础架构已经存在,可以检测复发性中风,使我们处于独特之处
使用新获得的放射学数据开发复发性中风风险模型的位置
效率。拟议的研究将允许对整个人群的第一个也是唯一的基于人群的表征
中风/TIA患者大脑健康的成像范围。我们的多学科团队具有成像,
流行病学,成果和生物统计学专业知识将精确地解决NINDS优先研究领域
和创新目前不可用。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Automated grading of enlarged perivascular spaces in clinical imaging data of an acute stroke cohort using an interpretable, 3D deep learning framework.
- DOI:10.1038/s41598-021-04287-4
- 发表时间:2022-01-17
- 期刊:
- 影响因子:4.6
- 作者:Williamson BJ;Khandwala V;Wang D;Maloney T;Sucharew H;Horn P;Haverbusch M;Alwell K;Gangatirkar S;Mahammedi A;Wang LL;Tomsick T;Gaskill-Shipley M;Cornelius R;Khatri P;Kissela B;Vagal A
- 通讯作者:Vagal A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRETT M KISSELA其他文献
BRETT M KISSELA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRETT M KISSELA', 18)}}的其他基金
APRISE Dementia (Assessing Population-based Radiological brain health in Stroke Epidemiology-Dementia)
APRISE 痴呆(中风流行病学-痴呆中基于人群的放射学脑健康评估)
- 批准号:
10029149 - 财政年份:2020
- 资助金额:
$ 57.44万 - 项目类别:
Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) Study
评估中风流行病学中基于人群的放射学脑健康 (APRISE) 研究
- 批准号:
10220148 - 财政年份:2018
- 资助金额:
$ 57.44万 - 项目类别:
Assessing Population-based Radiological brain health in Stroke Epidemiology (APRISE) Study
评估中风流行病学中基于人群的放射学脑健康 (APRISE) 研究
- 批准号:
9975234 - 财政年份:2018
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
6696309 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
7004481 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
6560309 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
6826225 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Outcome and Quality of Life after Diabetic Stroke
糖尿病中风后的结果和生活质量
- 批准号:
7162975 - 财政年份:2003
- 资助金额:
$ 57.44万 - 项目类别:
Comparison of Hemorrhagic & Ischemic Stroke Among Blacks and Whites
出血性比较
- 批准号:
8520995 - 财政年份:1992
- 资助金额:
$ 57.44万 - 项目类别:
Comparison of Hemorrhagic & Ischemic Stroke Among Blacks and Whites
出血性比较
- 批准号:
7654859 - 财政年份:1992
- 资助金额:
$ 57.44万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
2/2 血管疾病的改善结果 - 主动脉夹层 (IMPROVE-AD)
- 批准号:
10663555 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
Alveolar Dead Space and New or Progressive MODS
肺泡死腔和新的或进展性 MODS
- 批准号:
10740810 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
1/2 改善血管疾病的结果 - 主动脉夹层 (IMPROVE-AD)
- 批准号:
10663037 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
All of Us Research Program Heartland Consortium (AoURP-HC)
我们所有人研究计划中心联盟 (AoURP-HC)
- 批准号:
10871732 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别:
1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
1/4-美国早期肝移植联盟-前瞻性酒精相关性肝病队列评估(ACCELERATE-PACE)
- 批准号:
10711811 - 财政年份:2023
- 资助金额:
$ 57.44万 - 项目类别: